Total or near-total loss of insulin-producing β-cells is a situation found in diabetes (Type 1, T1D) 1,2 . Restoration of insulin production in T1D is thus a major medical challenge. We previously observed in mice in which β-cells are completely ablated that the pancreas reconstitutes new insulin-producing cells in absence of autoimmunity 3 . The process involves the contribution of islet non-β-cells; specifically, glucagon-producing α-cells begin producing insulin by a process of reprogramming (transdifferentiation) without proliferation 3 . Here we studied the influence of age on β-cell reconstitution from heterologous islet cells after near-total β-cell loss. We found that senescence does not alter α-cell plasticity: α-cells can reprogram to produce insulin from puberty through adulthood, and also in aged individuals, even a long-time after β-cell loss. In contrast, prior to puberty there is no detectable α-cell conversion, although β-cell reconstitution after injury is more efficient, always leading to diabetes recovery; it occurs through a newly discovered mechanism: the spontaneous en masse reprogramming of somatostatin-producing δ-cells. The younglings display "somatostatin-to-insulin" δ-cell conversion, involving de-differentiation, proliferation and re-expression of islet developmental regulators. This juvenile adaptability relies, at least in part, upon combined action of FoxO1 and downstream effectors. Restoration of insulin producing-cells from non-β-cell origins is thus enabled throughout life via δ-or α-cell spontaneous reprogramming. A landscape with multiple intra-islet cell interconversion events is emerging, thus offering new perspectives.
To determine how ageing affects the mode and efficiency of β-cell reconstitution after β-cell loss, we administered diphtheria toxin (DT) to adult (2-month-old) or aged (1-and 1.5-yearold) RIP-DTR mice, whose β-cells bear DT receptors 3 , and followed them for up to 14 months. Collectively, we found that α-to-β cell conversion is the main mechanism of insulin cell generation after massive β-cell loss in adult post-pubertal mice, whether middle-aged or very old, and α-cells are progressively recruited into insulin production with time (Extended Data Fig.1 ; Supp. Tables S1-5).
In this study we focused on the regeneration potential during early postnatal life by inducing β-cell ablation before weaning, at 2 weeks of age (Fig. 1a) . We found that prepubescent mice rapidly recover from diabetes after near-total β-cell loss: four months later all younglings were almost normoglycemic, thus displaying a faster recovery relative to adults ( Histologically, 99% of the β-cells were lost at 2 weeks following DT administration (Fig.  1c) . The β-cell number increased by 45-fold 4 months after ablation, representing 23% of the normal age-matched β-cell mass ( Fig. 1c ; Supp. Table S6 ) and correlating with normoglycemia recovery 1 .
All animals remained normoglycemic during the rest of their life (Supp. Table S6 ). Mice were neither intolerant to glucose nor insulin resistant during the period of analysis, up to 15 months after injury (Extended Data Fig. 2c -e).
We investigated whether the new insulin + cells were reprogrammed α-cells, as in adults, using Glucagon-rtTA; TetO-Cre; R26-YFP; RIP-DTR pups (Fig. 1d) . We observed that almost no insulin + cell co-expressed YFP or glucagon (Supp. Table S7 ), indicating that α-cells do not reprogram in younglings.
We further explored the age-dependency of rescue after near-total β-cell loss. To this aim, normoglycemic 5-month-old mice, which had recovered from β-cell loss at 2 weeks of age, were re-administered DT to ablate the regenerated insulin + cells. One month following the second ablation, 30% of the insulin-containing cells also contained glucagon (Extended Data Fig.2f ; Supp. Table S8) , like β-cell-ablated adults (Extended Data Fig. 1k ), confirming that the pre-pubertal regeneration mechanism is restricted temporally. We measured proliferation rates at different time-points during 2 months of regeneration. The proportion of Ki67-labeled insulin + cells was very low (Extended Data Fig.2g ; Supp. Table S9 ), indicating that neither escaping β-cells nor regenerated insulin + cells proliferate during this period. However, there was a transient 3.5-fold increase in the number of insular Ki67 + cells 2 weeks after ablation, unlike in adult animals (Extended Data Fig.2h ; Supp. Table S10 ). Replicating cells were hormone-negative, chromogranin A-negative, and were not lineage-traced to either α-or escaping β-cells (Extended Data Fig.2i,j) . cells and observed that regenerated insulin-producing cells were dedifferentiated δ-cells. At 2 months of age in Somatostatin-Cre; R26-YFP; RIP-DTR mice, about 81% of δ-cells were YFP + in the absence of β-cell ablation, whereas α-and β-cells were labeled at background levels (0.9% for β-cells and 0.2% for α-cells; Extended Data Fig.3c,d , Supp. Table S12) . During β-cell reconstitution in pups, 2 weeks after β-cell ablation, 80% of YFP + cells were proliferating (Ki67 + ) and somatostatin-negative ( Fig. 2a,b ; Supp. Table S13), while most Ki67 + cells were YFP-labeled (85%; Supp. Table S14 ).
These observations suggest that in β-cell-ablated pre-pubertal mice most δ-cells undergo a loss of somatostatin expression and enter the cell cycle.
We further investigated the fate of proliferating dedifferentiated δ-cells. At 1.5 months postablation, most insulin + cells expressed YFP (90%), indicating their δ-cell origin ( Fig. 2c,d ; Supp. Table S15 ). Furthermore, in contrast to non-ablated age-matched controls, where all YFP + cells were somatostatin + (>99%), about half of YFP + cells were insulin + after 1.5 months of regeneration (45%; Fig. 2e ; Supp. Table S16 ). This reveals that half of the progeny of dedifferentiated δ-cells becomes insulin expressers. Bihormonal somatostatin + / insulin + cells were rare (Supp . Table S17 ).
Combined, these observations show that at the cell population level, each dedifferentiated δ-cell yields one insulin expresser cell and one somatostatin + cell(Extended Data Fig.4 ).
We confirmed with two other assays that regeneration and diabetes recovery in juvenile mice are δ-cell-dependent: by inducing β-cell destruction with streptozotocin (STZ) instead of DT (Extended Data Fig.5a-c) , and by co-ablating β-and δ-cells simultaneously in Somatostatin-Cre; R26-YFP; R26-iDTR; RIP-DTR pups. In absence of δ-cells there was no insulin + cell regeneration, and no recovery (Fig. 2f) .
In adults, δ-cells neither de-differentiated nor proliferated following β-cell ablation (Extended Data. Fig.5d ,e; Supp. Table S20 ). Nevertheless, like α-cells, a few δ-cells reprogrammed into insulin production, so that after 1.5 month of regeneration 17% of the rare insulin-producing cells were YFP + , i.e. δ-cell-derived (Extended Data Fig. 5f -h; Supp. Tables S21, S22) .
By transplanting Somatostatin-Cre; R26-YFP; RIP-DTR juvenile islets into adult wild-type mice we observed that, following β-cell ablation, the newly formed insulin + cells were reprogrammed δ-cells, thus showing that the pup-specific regeneration is intrinsic to islets (Extended Data Fig.6 ).
Contrary to β-cells in age-matched adult mice, δ-cell-derived insulin + cells replicated transiently (Extended Data Fig.7a ; Supp. Table S23) ; the β-cell mass thus reached between 30% to 69% of the normal values, and remained stable for life (above, Supp. Table S6 ).
We characterized the δ-cell-derived insulin + cells at the gene expression level by qPCR. We first compared islets isolated 2 weeks after β-cell ablation or after recovery (4 months post-DT), with age-matched control islets. Expression of all the β-cell-specific markers tested was robustly increased in recovered mice (Extended Data Fig.7b ). We also compared regenerated insulin + cells with native β-cells using sorted mCherry + cells obtained from either recovered or unablated age-matched (4.5-month-old) insulin-mCherry; RIP-DTR mice (Extended Data Fig.7c ). The two cell populations were very similar (Extended Data Fig.7d ), yet the δ-cell-derived replicating β-cells displayed apotent downregulation of cyclindependent kinase inhibitors and regulators (Extended Data Fig.7e,f) . This suggests that reconstituted insulin + cells are like β-cells with transient proliferation capacity. Future studies will establish whether reconstituted (δ)β-like cells are true equivalents to native β-cells.
qPCR and lineage-tracing analyses on islets isolated from pups at different regeneration time-points, together with Ngn3 KO induction after β-cell ablation, revealed that Ngn3transcription is required for the δ-to-insulin + cell conversion to occur (Extended Data Fig.8a -k, Supp. Tables S24-S29). Of note, brief expression of Ngn3 is a feature of islet precursor cells in the embryonic pancreas 4 . Together, these observations are compatible with a model in which β-cell reconstitution after ablation in younglings occurs following a sequence of events: δ-cells dedifferentiate, replicate once and then half of the progeny activates Ngn3 expression before insulin production (Fig. 2g) . This was tested in a combined double lineage-tracing experiment using Somatostatin-Cre; R26-Tomato; Ngn3-YFP; RIP-DTR mice. Six weeks post-β-cell ablation, insulin + cells in younglings were Tomato + /YFP + (Extended Data Fig.8k ).
One key reprogramming and cell cycle entry player is FoxO1, a transcription factor whose downregulation triggers Ngn3 expression in human fetal pancreatic explants 5 and favors insulin production in Ngn3 + entero-endocrine progenitors 6 . FoxO1, usually in cooperation with TGFβ/SMAD signaling 7, 8 , inhibits cell proliferation through the transcriptional regulation of cell cycle inhibitors and activators 18 , and is involved in cellular senescence 7 (Extended Data Fig.9a ). We then explored the FoxO1 molecular network in purified adult or juvenile δ-cells before and after (1-week) β-cell ablation, using Somatostatin-Cre; R26-YFP; RIP-DTR mice.
δ-cells displayed a divergent regulation of FoxO1 in injured juvenile and adult mice.
Consistent with FoxO1 downregulation in juvenile δ-cells, PDK1 and AKT levels were increased, cdkn1a/p21 and cdkn2b/p15Ink4b were downregulated, and CKS1b, CDK2 and SKP were upregulated (Fig. 3a) , which is compatible with the proliferative capacity of juvenile δ-cells after β-cell ablation. The opposite was found in δ-cells of ablated adults ( Fig.  3a; Extended Data Fig.9b ).
Moreover, in δ-cells of younglings, but not in adults, there was a robust upregulation of BMP1/4 downstream effectors (Fig. 3b) 9, 10 . Inversely, TGFβ pathway genes were upregulated in δ-cells of regenerating adults (Fig. 3b) , which is compatible with the senescence scenario 7 systems 9, 10 (Fig. 3c) . Conversely, the PI3K/AKT pathway remained downregulated in δ-cells of ablated adults, which would allow FoxO1 to impede proliferation and dedifferentiation, probably through partnership with previously described SMADs 11 (Extended Data Fig.9b ).
We then checked whether a transient FoxO1 inhibition in adult mice would lead to a juvenile-like δ-to-β cell conversion. Indeed, inactivation of FoxO1 in β-cells causes their dedifferentiation 12 . Here, Somatostatin-Cre; R26-YFP; RIP-DTR β-cell-ablated adult mice were given a FoxO1 inhibitor (AS1842856) for 1 week, either immediately following ablation (Fig. 3d ) or 1 month later (Extended Data Fig.10f ; Supp. Tables S37-S39) 13, 14 . While FoxO1 inhibition in non-ablated controls had minimal effect on insulin expression (Extended Data Fig.10a-d ; Supp . Tables S30-S32 ), regeneration in diabetic mice was improved: insulin + cells were more abundant (11-fold; Fig. 3e ,f; Supp. Table S33 ), and were reprogrammed δ-cells (93% were YFP + , Fig. 3g ; Supp. Table S34 ). One-fourth of the YFP + cells expressed insulin only ( Fig. 3h ; Extended Data Fig.10e ; Supp. Tables S35, S36 ), revealing that, like in younglings, an important fraction of δ-cells had converted to insulin production.
These results support the involvement of a regenerative FoxO1 network and confirm that δ-cell conversion can be pharmacologically induced in diabetic adults. FoxO1 blockade has a pleiotropic effect: inhibition of hepatic gluconeogenesis 13, 14 and promotion of δ-cell reprogramming (this study).
A century ago Morgan coined the terms epimorphosis and morphallaxis to designate, respectively, regeneration involving either cell dedifferentiation and proliferation or direct conversion from one cell type into another without proliferation 15 . Here we report in mammals an age-dependent switch ("adult transition") between epimorphic regeneration during youth, and a less efficient yet persistent throughout life proliferation-independent morphallactic mechanism.
Our findings uncover a novel role for δ-cells; perhaps somatostatin + cells in the stomach, intestine or hypothalamus share the same capabilities. Intra-islet cell plasticity triggered by the disappearance of β-cells is influenced by age: the proliferation decline in ageing cells 16 would explain the need of an "adult transition". Although less efficient, α-cell plasticity remains long-time after β-cell loss since it is proliferation-independent.
These phenomena might be translatable to humans, for there is efficient β-cell regeneration in children with T1D or after pancreatectomy 3, [17] [18] [19] , and glucagon/insulin bihormonal human cells have been described upon epigenetic manipulation ex vivo 20 , and in diabetic patients 21, 22 . Knowing also that only a small fraction of the α-cell population is sufficient to maintain glucagon signaling 23 , understanding the nature of the diverse forms of intra-islet cell conversion might provide new opportunities to fostering the formation of (α)β-like and (δ)β-like cells. 
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Evolution of glycemia in 14 aged mice during 14 months post-ablation ("mpa"). Mice were treated with insulin for 4.5 months; most of them (5/7 in each group) subsequently recovered from diabetes. c-e) Pancreatic islets before (c) and after (d, e) β-cell ablation in 1.5-year-old mice; β-cell mass increases 3.5-fold between 0.5 and 1 mpa, 12-fold at 7 mpa and 32-fold at 14 mpa, in all age groups. 0.3% and 4.4% indicate β-cell mass relative to unablated controls (Supp . Table S1 , 2-month-old: n (0.5mpa) =4, n (1mpa )=4, n (7mpa) =4; 1-year-old: n (0.5mpa) =5, n (1mpa) =5, n (7mpa) =5, n (14mpa) =8; 1.5-year-old: n (0.5mpa) =3 , n (1mpa) =3, n (7mpa) =3 , n (14mpa) =8). f) β-cell proliferation is very low in aged mice, whether control (1.5%, n=8, 39,790 insulin + -cells scored) or ablated (0.2%, n=6, 938 790 insulin + -cells scored) (Supp .  Table S2 ). g) Proportion of insulin + cells also containing glucagon after DT is not different between groups (Supp. . e) Insulin tolerance tests (ITT) performed 1,5 year after β-cell ablation at 2 weeks of age (controls: n=7; DT: n=10). f) 4.5 months after β-cell ablation (at 2 weeks), 3 mice became normoglycemic and received a second treatment with DT. Ablation of regenerated insulin + -cells in recovered mice leads to the appearance of glucagon + /insulin + cells, corresponding to the type of "α-cell-dependent" regeneration observed in adults (31% of insulin+ cells also contained glucagon, Supp. Table S8 ). Arrow: glucagon + /insulin + bihormonal cell; error bars: s.e.m. g) β-cell proliferation is very low in regenerating pups (Supp. 
Extended Data Figure 4. δ-cells dedifferentiate, proliferate and reprogram into insulin production after extreme β-cell loss in juvenile mice
Observed and expected numbers of somatostatin + and insulin + cells per islet section, before and after β-cell ablation. Cells scored after 6 weeks (Extended Data Fig. 3a ) correspond (χ 2 test) with estimates made assuming that dedifferentiated proliferating δ-cells yield 2 types of progeny (as deduced from Fig. 2c,e) . Dashed arrows, phenotypic stability; plain arrows, dynamic behavior (dedifferentiation and replication). Once differentiated from δ-cells (YFP + ), the newly formed β-cells re-enter the cell cycle (Ki67 + cells). Two waves of massive replication occur, at 3 and 4 months after injury, respectively (Supp. Table S23 ). b) qPCR for β-cell-specific genes using RNA extracted from islets isolated from control and DT-treated mice, either 2 weeks or 4 months following DT administration ("0.5 mpa" and "4 mpa"). Note that after an initial extreme downregulation of all the β-cell-specific markers explored, their levels significantly recover after 4 months, which correlates with the observed robust regeneration and diabetes recovery. Values represent the ratio between each regeneration time-point and its age-matched control. c) Experimental design. d) qPCR comparison between regenerated cherry + /insulin + cells isolated from mice 4 months after β-cell ablation, and cherry + β-cells obtained from agematched controls (4.5-month-old). All markers tested are expressed at identical levels in both groups; non-β-cell markers are expressed at extremely reduced levels (CT ranging from 28 to 31), showing the same degree of purity in both types of cell preparations. e, f) Interestingly, in contrast to bona fide β-cells isolated from 4.5-month-old controls, regenerated insulin + cells have lower levels of cyclin-dependent kinase inhibitors, FoxO1 and Smad3. This correlates with their increased proliferative capacity at this specific timepoint. Scale bars: 20 μm; qPCRs: n=3 mice/group, each individual sample of each experimental group was run in triplicate, in 3 independent reactions); built-in Welch's test; error bars: s.d. 
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